Advanced search
Publication Cover
Immunological Medicine Volume 42, 2019 - Issue 4
Submit an article Journal homepage
1,832
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Prognostic value of IL-34 in colorectal cancer patients

Takuto KobayashiDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
,
Muhammad BaghdadiDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
,
Nanumi HanDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
,
Tomoki MurataDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
,
Naoki HamaDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
,
Ryo OtsukaDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
,
Haruka WadaDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
,
Manabu ShiozawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan; View further author information
,
Tomoyuki YokoseDepartment of Pathology, Kanagawa Cancer Center, Yokohama, Japan; View further author information
,
Yohei MiyagiMolecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan; View further author information
,
Atsushi TakanoDepartment of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Japan; ;Center for Advanced Medicine against Cancer, Shiga University of Medical Science, Otsu, Japan; ;Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science, the University of Tokyo, Tokyo, JapanView further author information
,
Yataro DaigoDepartment of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Japan; ;Center for Advanced Medicine against Cancer, Shiga University of Medical Science, Otsu, Japan; ;Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science, the University of Tokyo, Tokyo, JapanView further author information
&
Ken-Ichiro SeinoDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; Correspondence[email protected]
View further author information
 show all
Pages 169-175 | Received 14 Jun 2019, Accepted 03 Nov 2019, Published online: 23 Nov 2019

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
  • Araghi M, Soerjomataram I, Jenkins M, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 2019;144:2992–3000.
  • Visconti L, Nelissen K, Deckx L, et al. Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients. Biomarkers Med. 2014;8:297–306.
  • Kotowicz B, Fuksiewicz M, Jonska-Gmyrek J, et al. The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease. Tumor Biol. 2016;37:1271–1278.
  • Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science. 2008;320:807–811.
  • Baghdadi M, Umeyama Y, Hama N, et al. Interleukin-34, a comprehensive review. J Leukoc Biol. 2018;104:931–951.
  • Baghdadi M, Endo H, Tanaka Y, et al. Interleukin 34, from pathogenesis to clinical applications. Cytokine. 2017;99:139–147.
  • Baud’huin M, Renault R, Charrier C, et al. Interleukin-34 is expressed by giant cell tumors of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol. 2010;221:77–86.
  • Cioce M, Canino C, Goparaju C, et al. Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation. Cell Death Dis. 2014;5:e1167.
  • Ségaliny A, Mohamadi A, Dizier B, et al. Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. Int J Cancer. 2015;137:73–85.
  • Baghdadi M, Wada H, Nakanishi S, et al. Chemotherapy-induced IL34 enhances immunosuppression by tumor-associated macrophages and mediates survival of chemoresistant lung cancer cells. Cancer Res. 2016;76:6030–6042.
  • Zhou S, Hu Z, Zhou Z, et al. miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis. Hepatology. 2016;63:1560–1575.
  • Franzè E, Dinallo V, Rizzo A, et al. Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue. Oncotarget. 2017;9:3432–3445.
  • Raggi C, Correnti M, Sica A, et al. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages. J Hepatol. 2017;66:102–115.
  • Baghdadi M, Endo H, Takano A, et al. High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers. Sci Rep.. 2018;8:418.
  • Han N, Baghdadi M, Ishikawa K, et al. Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma. Inflamm Regen. 2018;38:3.
  • Baghdadi M, Ishikawa K, Endo H, et al. Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report. Inflamm Regen. 2018;38:12.
  • Baghdadi M, Ishikawa K, Nakanishi S, et al. A role for IL-34 in osteolytic disease of multiple myeloma. Blood Adv. 2019;3:541–551.
  • Franzè E, Monteleone I, Cupi ML, et al. Interleukin-34 sustains inflammatory pathways in the gut. Clin Sci. 2015;129:271–280.
  • Hoadley KA, Yau C, Hinoue T, et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 2018;173:291–304.
  • Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012;2:401–404.
  • Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013;6:pl1.
  • Zwicker S, Martinez GL, Bosma M, et al. Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clin Sci. 2015;129:281–290.
  • Yamashita K, Watanabe M. Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci. 2009;100:195–199.
  • Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer. 2002;2:210–219.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.